/Companies

Curapath

1 known investors

Find your way into Curapath

Sign up to find every way you can get introduced to Curapath

  • Your email: who you already know at Curapath, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Curapath team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies. The company develops and manufactures lipid nanoparticles, polymer nanoparticles, and delivery components from early development through GMP-certified commercial manufacturing for oncology, cell and gene therapy, and vaccine applications.

Founders & leadership

P
PhilippeChief Executive Officer
V
VicentChief Technology Officer

Investors · 1

In the news

Frequently asked questions

What does Curapath do?
Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies. The company develops and manufactures lipid nanoparticles, polymer nanoparticles, and delivery components from early development through GMP-certified commercial manufacturing for oncology, cell and gene therapy, and vaccine applications.
Who are Curapath's investors?
Curapath's investors include Columbus Venture Partners.